Were the changes to Sweden's maintenance treatment policy 2000-06 related to changes in opiate-related mortality and morbidity?

Addiction

Volumn 105, Issue 9, 2010, Pages 1625-1632

  Romelsjö, Anders ^a,b   Engdahl, Barbro ^b   Stenbacka, Marlene ^a,c   Fugelstad, Anna ^a,c   Davstad, Ingrid ^a,c   Leifman, Anders ^a,c   Thiblin, Ingemar ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c Stockholm Addiction Centre   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Buprenorphine; methadone; morbidity; mortality; opiate dependence; treatment policy

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANTAGONIST;

ADULT; ARTICLE; CLINICAL PROTOCOL; DRUG DEPENDENCE TREATMENT; FEMALE; HOSPITALIZATION; HUMAN; INTOXICATION; MALE; MORTALITY; OPIATE ADDICTION; PRACTICE GUIDELINE; SUBSTANCE ABUSE; SWEDEN;

ADULT; BUPRENORPHINE; CLINICAL PROTOCOLS; FEMALE; HOSPITALIZATION; HUMANS; MALE; METHADONE; MORTALITY; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; OVERDOSE; PRACTICE GUIDELINES AS TOPIC; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; SWEDEN; YOUNG ADULT;

EID: 77955379908     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.02999.x     Document Type: Article

References (26)

1. Dole V. P., Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction - a clinical trial with methadone hydrochloride. JAMA 1965 193 : 583 590.
2. Socialstyrelsen 'National Board of Health and Welfare'. Metadonregistret 'The Methadone Register'. Stockholm : Socialstyrelsen 2006.
3. Socialstyrelsen 'National Board of Health and Welfare'. Underhållsbehandling vid opiatberoende 'Maintenance Treatment of Opiate Dependence'. Stockholm : Socialstyrelsen 2006.
4. Davstad I., Stenbacka M., Leifman A., Beck O., Korkmaz S., Romelsjö A. Illicit drug use patterns and retention in a methadone programme using frequent urinalyses. J Opioid Manag 2007 3 : 27 34.
5. Olsson B., Adamsson Wahren C., Byqvist S. Det tunga narkotikamissbrukets omfattning i Sverige 'The Prevalence of Heavy Drug Abuse in Sweden' Maxprojektet, delrapport 3. Stockholm : Central förbundet för alcohol- och narkotikaupplysning 'The central council for information about alcohol and drugs' 2001 (in Swedish).
6. Central förbundet för alcohol- och narkotikaupplysning (CAN) 'The Central Council for Alcohol and Drug Information'. Drogutvecklingen i Sverige 2008 'Drug Development in Sweden in 2008'. Stockholm : CAN 2008.
7. Stenbacka M., Romelsjö A. Beskrivning och utvärdering av metadonbehandlingen i Sverige 'Description and Evaluation of Methadone Treatment in Sweden' Vetenskaplig rapport/Scientific report. Stockholm : Socialstyrelsen 1997 (in Swedish, English summary).
8. Stenbacka M., Leifman A., Romelsjo A. The impact of methadone treatment on registered convictions and arrests in HIV-positive and HIV-negative men and women with one or more treatment periods. Drug Alcohol Rev 2003 22 : 27 34.
9. Gunne L., Grönbladh L., Öhlund L. Treatment characteristics and retention in methadone maintenance: high and stable retention rates in a Swedish two-phase programme. Heroin Addict Relat Clin Probl 2002 4 : 37 46.
10. Kakko J., Dybrandt Svanborg K., Kreek M. J., Heilig M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet 2003 361 : 662 668.
11. Läkemedelsindustriföreningen 'The Swedish Association of the Pharmaceutical Industry'. Farmaceptiska specialiteter (FASS) i Sverige 'Pharmaceutical Specialities in Sweden'. Stockholm : Lä kemedelsindustriföreningen 2005.
12. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The State of the Drugs Problem in Europe. Annual Report 2008. Lisbon : EMCDDA 2008.
13. Auriacombe M., Fatseas M., Dubernet J., Daulouède J. P., Tignol J. French field experience with buprenorphine. Am J Addict 2001 13 : S17 28.
14. Engdahl B., Romelsjö A., Sand M. Behandling av opiatmissbrukare i Sverige med Subutex 2000-2005 - en studie av ändrad behandlingspolicy? 'Treatment of Opiate Dependent Persons in Sweden with Buprenorphine 2005-2006 - A Study of Changed Treatment Policy?'. Forskningsrapport nr. 35/Research report no. 35. Stockholm : Stockholm University, SoRAD 2006.
15. Apoteket Sverige, Statistikenheten 'The National Drug Company, The Statistical Unit'. Data on Sales of Methadone and Buprenoprphine 2000-2006. Stockholm : Apoteket 2008.
16. World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology in Oslo. Data on drug sales 2008. Available at: http://www.whocc.no (accessed 1990.
17. Folkhälsoinstitutet 'National Public Health Institute'. Narkotikarelaterad dödlighet baserad på rättsmedicinska data 'Drug-Related Mortality Based on Forensic Data'. Östersund : Folkhälsoinstitutet 2007.
18. Socialstyrelsen 'National Board of Health and Welfare'. Nationella läkemedelsregistret 'The National Drug Register'. Stockholm : Socialstyrelsen 2008.
19. Statistical Bulletin. 2009. Available at: http://www.emcdda.europa.eu/ drug-situation (accessed 10 November 2009).
20. Statistical Bulletin. 2009. Available at: http://www.emcdda.europa.eu/ drug-situation (accessed W., Lynskey M., Degenhart L. J. Trends in opiate-related deaths in the United Kingdom and Australia, 1985-1995. Drug Alcohol Depend 2000 57 : 247 254.
21. Fingerhut L. Increases in Poisoning and Methadone-Related Deaths: United States, 1999-2005. Washington, DC : National Centre for Health Statistics 2005.
22. Fugelstad A., Stenbacka M., Leifman A., Nylander M., Thiblin I. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction 2007 102 : 406 412.
23. Håkansson A., Medvedeo A., Andersson M., Berglund M. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration. Eur Addict Res 2007 13 : 207 215.
24. Pirnay S., Borron S. W., Giudicelli C. P., Tourneau J., Baud F. J., Ricordel I. A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction 2004 99 : 978 988.
25. Escots S., Fahet G. Usages non substitutifs de la buprénorphine haut dosage. Investigation meneé en France en 2002-2003. Paris, TREND, OFTD (observatoire francais des drogues et des toxicomanies); 2004.
26. Fatses M., Auriacombe M. Why buprenorphine is so successful in treating opiate addiction in France. Curr Psychiatry Rep 2007 9 : 358 364.